Severe acute respiratory syndrome in dialysis patients.
Identifieur interne : 002D08 ( PubMed/Curation ); précédent : 002D07; suivant : 002D09Severe acute respiratory syndrome in dialysis patients.
Auteurs : Bonnie Ching-Ha Kwan [Hong Kong] ; Chi-Bon Leung ; Cheuk-Chun Szeto ; Vincent Wai-Sun Wong ; Yuk-Lun Cheng ; Alex Wai-Yin Yu ; Philip Kam-Tao LiSource :
- Journal of the American Society of Nephrology : JASN [ 1046-6673 ] ; 2004.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Anémie hémolytique (métabolisme), Coronavirus (métabolisme), Dialyse péritonéale (effets indésirables), Dialyse rénale (effets indésirables), Facteurs temps, Femelle, Hospitalisation, Humains, Lutte contre l'infection, Maladies transmissibles émergentes, Modèles statistiques, Mâle, Réaction de polymérisation en chaîne, Résultat thérapeutique, Sujet âgé, Syndrome respiratoire aigu sévère (étiologie), Virus du SRAS (métabolisme), Études cas-témoins.
- MESH :
- effets indésirables : Dialyse péritonéale, Dialyse rénale.
- métabolisme : Anémie hémolytique, Coronavirus, Virus du SRAS.
- étiologie : Syndrome respiratoire aigu sévère.
- Adulte d'âge moyen, Facteurs temps, Femelle, Hospitalisation, Humains, Lutte contre l'infection, Maladies transmissibles émergentes, Modèles statistiques, Mâle, Réaction de polymérisation en chaîne, Résultat thérapeutique, Sujet âgé, Études cas-témoins.
English descriptors
- KwdEn :
- Aged, Anemia, Hemolytic (metabolism), Case-Control Studies, Communicable Diseases, Emerging, Coronavirus (metabolism), Female, Hospitalization, Humans, Infection Control, Male, Middle Aged, Models, Statistical, Peritoneal Dialysis (adverse effects), Polymerase Chain Reaction, Renal Dialysis (adverse effects), SARS Virus (metabolism), Severe Acute Respiratory Syndrome (etiology), Time Factors, Treatment Outcome.
- MESH :
- adverse effects : Peritoneal Dialysis, Renal Dialysis.
- etiology : Severe Acute Respiratory Syndrome.
- metabolism : Anemia, Hemolytic, Coronavirus, SARS Virus.
- Aged, Case-Control Studies, Communicable Diseases, Emerging, Female, Hospitalization, Humans, Infection Control, Male, Middle Aged, Models, Statistical, Polymerase Chain Reaction, Time Factors, Treatment Outcome.
Abstract
Reviewed are the clinical features and outcome of 12 chronic dialysis patients (six men) who contracted severe acute respiratory syndrome (SARS) compared with 23 sex- and age-matched nonuremic SARS patients as controls. Eight were on peritoneal dialysis (PD) and four on hemodialysis. Mean age was 58 +/- 12 yr for the dialysis patients, and 57 +/- 12 yr for the controls. The presenting symptoms of dialysis patients were similar to the controls. With appropriate protection measures, hemodialysis was performed in a dedicated area of the SARS isolation ward, while PD was continued as intermittent PD. In all seven patients with PD effluent tested, SARS-related coronavirus (CoV) could not be identified by polymerase chain reaction (PCR) or viral culture. Three dialysis patients had persistent positive stool PCR after 5 wk, whereas all nondialysis patients had negative stool PCR after 1 wk. Despite dosage adjustment, ribavirin-induced hemolytic anemia was more severe in the dialysis patients. Dialysis patients required longer hospitalization than the controls, but the mortality was similar. With appropriate protective measures, dialysis could be safely performed. Dialysis patients with SARS often require prolonged hospitalization. Furthermore, these patients may have an extended period of viral shedding, which should be carefully monitored for the purpose of infection control.
DOI: 10.1097/01.asn.0000131522.16404.1f
PubMed: 15213277
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002D08
Links to Exploration step
pubmed:15213277Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Severe acute respiratory syndrome in dialysis patients.</title><author><name sortKey="Kwan, Bonnie Ching Ha" sort="Kwan, Bonnie Ching Ha" uniqKey="Kwan B" first="Bonnie Ching-Ha" last="Kwan">Bonnie Ching-Ha Kwan</name><affiliation wicri:level="4"><nlm:affiliation>Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong SAR.</nlm:affiliation><orgName type="university">Université chinoise de Hong Kong</orgName><country>Hong Kong</country><placeName><settlement type="city">Sha Tin</settlement></placeName></affiliation></author><author><name sortKey="Leung, Chi Bon" sort="Leung, Chi Bon" uniqKey="Leung C" first="Chi-Bon" last="Leung">Chi-Bon Leung</name></author><author><name sortKey="Szeto, Cheuk Chun" sort="Szeto, Cheuk Chun" uniqKey="Szeto C" first="Cheuk-Chun" last="Szeto">Cheuk-Chun Szeto</name></author><author><name sortKey="Wong, Vincent Wai Sun" sort="Wong, Vincent Wai Sun" uniqKey="Wong V" first="Vincent Wai-Sun" last="Wong">Vincent Wai-Sun Wong</name></author><author><name sortKey="Cheng, Yuk Lun" sort="Cheng, Yuk Lun" uniqKey="Cheng Y" first="Yuk-Lun" last="Cheng">Yuk-Lun Cheng</name></author><author><name sortKey="Yu, Alex Wai Yin" sort="Yu, Alex Wai Yin" uniqKey="Yu A" first="Alex Wai-Yin" last="Yu">Alex Wai-Yin Yu</name></author><author><name sortKey="Li, Philip Kam Tao" sort="Li, Philip Kam Tao" uniqKey="Li P" first="Philip Kam-Tao" last="Li">Philip Kam-Tao Li</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2004">2004</date><idno type="RBID">pubmed:15213277</idno><idno type="pmid">15213277</idno><idno type="doi">10.1097/01.asn.0000131522.16404.1f</idno><idno type="wicri:Area/PubMed/Corpus">002D08</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002D08</idno><idno type="wicri:Area/PubMed/Curation">002D08</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002D08</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Severe acute respiratory syndrome in dialysis patients.</title><author><name sortKey="Kwan, Bonnie Ching Ha" sort="Kwan, Bonnie Ching Ha" uniqKey="Kwan B" first="Bonnie Ching-Ha" last="Kwan">Bonnie Ching-Ha Kwan</name><affiliation wicri:level="4"><nlm:affiliation>Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong SAR.</nlm:affiliation><orgName type="university">Université chinoise de Hong Kong</orgName><country>Hong Kong</country><placeName><settlement type="city">Sha Tin</settlement></placeName></affiliation></author><author><name sortKey="Leung, Chi Bon" sort="Leung, Chi Bon" uniqKey="Leung C" first="Chi-Bon" last="Leung">Chi-Bon Leung</name></author><author><name sortKey="Szeto, Cheuk Chun" sort="Szeto, Cheuk Chun" uniqKey="Szeto C" first="Cheuk-Chun" last="Szeto">Cheuk-Chun Szeto</name></author><author><name sortKey="Wong, Vincent Wai Sun" sort="Wong, Vincent Wai Sun" uniqKey="Wong V" first="Vincent Wai-Sun" last="Wong">Vincent Wai-Sun Wong</name></author><author><name sortKey="Cheng, Yuk Lun" sort="Cheng, Yuk Lun" uniqKey="Cheng Y" first="Yuk-Lun" last="Cheng">Yuk-Lun Cheng</name></author><author><name sortKey="Yu, Alex Wai Yin" sort="Yu, Alex Wai Yin" uniqKey="Yu A" first="Alex Wai-Yin" last="Yu">Alex Wai-Yin Yu</name></author><author><name sortKey="Li, Philip Kam Tao" sort="Li, Philip Kam Tao" uniqKey="Li P" first="Philip Kam-Tao" last="Li">Philip Kam-Tao Li</name></author></analytic><series><title level="j">Journal of the American Society of Nephrology : JASN</title><idno type="ISSN">1046-6673</idno><imprint><date when="2004" type="published">2004</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Anemia, Hemolytic (metabolism)</term><term>Case-Control Studies</term><term>Communicable Diseases, Emerging</term><term>Coronavirus (metabolism)</term><term>Female</term><term>Hospitalization</term><term>Humans</term><term>Infection Control</term><term>Male</term><term>Middle Aged</term><term>Models, Statistical</term><term>Peritoneal Dialysis (adverse effects)</term><term>Polymerase Chain Reaction</term><term>Renal Dialysis (adverse effects)</term><term>SARS Virus (metabolism)</term><term>Severe Acute Respiratory Syndrome (etiology)</term><term>Time Factors</term><term>Treatment Outcome</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Anémie hémolytique (métabolisme)</term><term>Coronavirus (métabolisme)</term><term>Dialyse péritonéale (effets indésirables)</term><term>Dialyse rénale (effets indésirables)</term><term>Facteurs temps</term><term>Femelle</term><term>Hospitalisation</term><term>Humains</term><term>Lutte contre l'infection</term><term>Maladies transmissibles émergentes</term><term>Modèles statistiques</term><term>Mâle</term><term>Réaction de polymérisation en chaîne</term><term>Résultat thérapeutique</term><term>Sujet âgé</term><term>Syndrome respiratoire aigu sévère (étiologie)</term><term>Virus du SRAS (métabolisme)</term><term>Études cas-témoins</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Peritoneal Dialysis</term><term>Renal Dialysis</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Dialyse péritonéale</term><term>Dialyse rénale</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Anemia, Hemolytic</term><term>Coronavirus</term><term>SARS Virus</term></keywords><keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Anémie hémolytique</term><term>Coronavirus</term><term>Virus du SRAS</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Case-Control Studies</term><term>Communicable Diseases, Emerging</term><term>Female</term><term>Hospitalization</term><term>Humans</term><term>Infection Control</term><term>Male</term><term>Middle Aged</term><term>Models, Statistical</term><term>Polymerase Chain Reaction</term><term>Time Factors</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Facteurs temps</term><term>Femelle</term><term>Hospitalisation</term><term>Humains</term><term>Lutte contre l'infection</term><term>Maladies transmissibles émergentes</term><term>Modèles statistiques</term><term>Mâle</term><term>Réaction de polymérisation en chaîne</term><term>Résultat thérapeutique</term><term>Sujet âgé</term><term>Études cas-témoins</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Reviewed are the clinical features and outcome of 12 chronic dialysis patients (six men) who contracted severe acute respiratory syndrome (SARS) compared with 23 sex- and age-matched nonuremic SARS patients as controls. Eight were on peritoneal dialysis (PD) and four on hemodialysis. Mean age was 58 +/- 12 yr for the dialysis patients, and 57 +/- 12 yr for the controls. The presenting symptoms of dialysis patients were similar to the controls. With appropriate protection measures, hemodialysis was performed in a dedicated area of the SARS isolation ward, while PD was continued as intermittent PD. In all seven patients with PD effluent tested, SARS-related coronavirus (CoV) could not be identified by polymerase chain reaction (PCR) or viral culture. Three dialysis patients had persistent positive stool PCR after 5 wk, whereas all nondialysis patients had negative stool PCR after 1 wk. Despite dosage adjustment, ribavirin-induced hemolytic anemia was more severe in the dialysis patients. Dialysis patients required longer hospitalization than the controls, but the mortality was similar. With appropriate protective measures, dialysis could be safely performed. Dialysis patients with SARS often require prolonged hospitalization. Furthermore, these patients may have an extended period of viral shedding, which should be carefully monitored for the purpose of infection control.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15213277</PMID><DateCompleted><Year>2004</Year><Month>11</Month><Day>19</Day></DateCompleted><DateRevised><Year>2019</Year><Month>06</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1046-6673</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><Issue>7</Issue><PubDate><Year>2004</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal of the American Society of Nephrology : JASN</Title><ISOAbbreviation>J. Am. Soc. Nephrol.</ISOAbbreviation></Journal><ArticleTitle>Severe acute respiratory syndrome in dialysis patients.</ArticleTitle><Pagination><MedlinePgn>1883-8</MedlinePgn></Pagination><Abstract><AbstractText>Reviewed are the clinical features and outcome of 12 chronic dialysis patients (six men) who contracted severe acute respiratory syndrome (SARS) compared with 23 sex- and age-matched nonuremic SARS patients as controls. Eight were on peritoneal dialysis (PD) and four on hemodialysis. Mean age was 58 +/- 12 yr for the dialysis patients, and 57 +/- 12 yr for the controls. The presenting symptoms of dialysis patients were similar to the controls. With appropriate protection measures, hemodialysis was performed in a dedicated area of the SARS isolation ward, while PD was continued as intermittent PD. In all seven patients with PD effluent tested, SARS-related coronavirus (CoV) could not be identified by polymerase chain reaction (PCR) or viral culture. Three dialysis patients had persistent positive stool PCR after 5 wk, whereas all nondialysis patients had negative stool PCR after 1 wk. Despite dosage adjustment, ribavirin-induced hemolytic anemia was more severe in the dialysis patients. Dialysis patients required longer hospitalization than the controls, but the mortality was similar. With appropriate protective measures, dialysis could be safely performed. Dialysis patients with SARS often require prolonged hospitalization. Furthermore, these patients may have an extended period of viral shedding, which should be carefully monitored for the purpose of infection control.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kwan</LastName><ForeName>Bonnie Ching-Ha</ForeName><Initials>BC</Initials><AffiliationInfo><Affiliation>Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong SAR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leung</LastName><ForeName>Chi-Bon</ForeName><Initials>CB</Initials></Author><Author ValidYN="Y"><LastName>Szeto</LastName><ForeName>Cheuk-Chun</ForeName><Initials>CC</Initials></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Vincent Wai-Sun</ForeName><Initials>VW</Initials></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Yuk-Lun</ForeName><Initials>YL</Initials></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Alex Wai-Yin</ForeName><Initials>AW</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Philip Kam-Tao</ForeName><Initials>PK</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Am Soc Nephrol</MedlineTA><NlmUniqueID>9013836</NlmUniqueID><ISSNLinking>1046-6673</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000743" MajorTopicYN="N">Anemia, Hemolytic</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D021821" MajorTopicYN="N">Communicable Diseases, Emerging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017934" MajorTopicYN="N">Coronavirus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017053" MajorTopicYN="N">Infection Control</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="N">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010530" MajorTopicYN="N">Peritoneal Dialysis</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016133" MajorTopicYN="N">Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006435" MajorTopicYN="N">Renal Dialysis</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045169" MajorTopicYN="N">Severe Acute Respiratory Syndrome</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>6</Month><Day>24</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>12</Month><Day>16</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>6</Month><Day>24</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15213277</ArticleId><ArticleId IdType="doi">10.1097/01.asn.0000131522.16404.1f</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002D08 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 002D08 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:15213277
|texte= Severe acute respiratory syndrome in dialysis patients.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:15213277" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |